Advertisement
Screener

CVRx, Inc. (CVRX) P/E Ratio

2.8 / 5 stars · 68/120 Roast Me

CVRx, Inc. PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

  • CVRx, Inc. pe ratio for the quarter ending 2026-06-30 was -2.62, a change of 0.32 year-over-year.
  • CVRx, Inc. pe ratio for the quarter ending 2026-03-31 was -4.73, a change of 1.45 year-over-year.
  • CVRx, Inc. pe ratio for the quarter ending 2025-12-31 was -3.51, a change of 1.84 year-over-year.
  • CVRx, Inc. pe ratio for the quarter ending 2025-09-30 was -4.07, a change of -0.43 year-over-year.
  • CVRx, Inc. pe ratio for fiscal 2026 was -2.62.
  • CVRx, Inc. pe ratio for fiscal 2025 was -3.51, a change of 1.84 from fiscal 2024.
  • CVRx, Inc. pe ratio for fiscal 2024 was -5.35, a change of 10.58 from fiscal 2023.
  • CVRx, Inc. pe ratio for fiscal 2023 was -15.93, a change of -6.78 from fiscal 2022.
Available history
2021-06-30 to 2026-06-30
Data captured

Historical PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-2.62$136.14M-$51.97M
2026-03-31-4.73$249.22M-$52.66M
2025-12-31-3.51$187.08M-$53.31M
2025-09-30-4.07$211.91M-$52.02M
2025-06-30-2.94$153.74M-$52.25M
2025-03-31-6.18$318.62M-$51.55M
2024-12-31-5.35$320.86M-$59.97M
2024-09-30-3.65$213.23M-$58.48M
2024-06-30-4.79$260.33M-$54.39M
2024-03-31-7.56$393.21M-$52.01M
2023-12-31-15.93$656.44M-$41.2M
2023-09-30-7.42$315.74M-$42.57M
2023-06-30-7.38$320.39M-$43.39M
2023-03-31-4.51$193.01M-$42.81M
2022-12-31-9.15$379.18M-$41.43M
2022-09-30-4.63$192M-$41.46M
2022-06-30-3.27$123.66M-$37.77M
2022-03-31-2.76$122.72M-$44.44M
2021-12-31-5.79$249.48M-$43.08M
2021-09-30-9.37$336.62M-$35.91M
2021-06-30-0.31$10.26M-$33M

Annual PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-2.62$136.14M-$51.97M
2025-12-31-3.51$187.08M-$53.31M
2024-12-31-5.35$320.86M-$59.97M
2023-12-31-15.93$656.44M-$41.2M
2022-12-31-9.15$379.18M-$41.43M
2021-12-31-5.79$249.48M-$43.08M

Similar stocks

Stock NameCountryMarket CapPE Ratio
DarioHealth Corp. (DRIO)$0.066B-1.39
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Pulmonx Corp (LUNG)United States$0.082B-1.16
Spectral AI, Inc. (MDAI)United States$0.052B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02